SCHEMBL5821663

SCHEMBL5821663

CCCC(CI)C1(CC)C(=O)NC(=O)NC1=O

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.61
KDM4E B2RXH2 1/20 0.61
ALDH1A1 P00352 1/20 0.61
GABRB3 P28472 1/20 0.61
OPRD1 P41143 1/20 0.61
GABRA2 P47869 1/20 0.61
GABRB2 P47870 1/20 0.61
MMP9 P14780 1/20 0.45
LMNA P02545 4/20 0.45
RECQL P46063 1/20 0.32
POLB P06746 1/20 0.32
PKM P14618 1/20 0.32
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabarbital SCHEMBL1643537 0.85 CYP3A4 (0.65) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Tetrabarbital SCHEMBL1643533 0.85 CYP3A4 (0.65) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL735353 0.76 CYP3A4 (1.00) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL24966 0.76 CYP3A4 (1.00) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL2376470 0.76 CYP3A4 (1.00) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL26056 0.74 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL26057 0.74 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL3695587 0.74 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL3245534 0.74 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL1256614 0.74 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006036928-A2 INHIBITORS OF MATRIX METALLOPROTEINASES TO TREAT NEUROLOGICAL DISORDERS WAYNE STATE UNIVERSITY (US) 2006-04-06 WO disclosed